54.77MMarket Cap-135P/E (TTM)
1.410High1.110Low186.02KVolume1.130Open1.060Pre Close242.29KTurnover1.16%Turnover RatioLossP/E (Static)39.12MShares17.17052wk High-0.28P/B22.49MFloat Cap0.91852wk Low--Dividend TTM16.07MShs Float17.170Historical High--Div YieldTTM28.30%Amplitude0.918Historical Low1.302Avg Price1Lot Size
AEON Biopharma Stock Forum
this is depressing. wonder will the counter just get itself delisted from the market? people just treat the compat withour any single hope?
NEWS
AEON Biopharma Announces Preliminary Top-Line Results from Phase 2 Interim Analysis of ABP-450 in the Preventive Treatment of Chronic Migraine
AEON Biopharma announced that the preliminary results from the Phase 2 trial with ABP-450 for chronic migraine prevention did not meet the primary endpoint of mean reduction in monthly migraine days. The trial showed no statistical significance in reduction compared to placebo, leading to the company initiating cash preserva...
Dow Jones· 5 mins ago
1 MINUTE AGO, 4:30 PM EDT
VIA GLOBENEWSWIRE
– FDA and AEON align on the design and endpoints for the proposed pivotal Phase 3 trials for the preventive treatment of both episodic and chronic migraine –
– An interim analysis from the ongoing Phase 2 study in chronic migraine will now be conducted and data are e...
https://www.koreabiomed.com/news/articleView.html?idxno=22014
No comment yet